Zeta Acquisition Corp II

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Zeta Acquisition Corp II
TickerWHWK
CIK #0001422142
CUSIP00032Q104
SectorReal Estate & Construction - Blank Checks
AddressEquity Dynamics Inc 666 Walnut Street Ste 2116, Des Moines, IA 50309
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
AADI Bioscience Inc 2025-03-18 100.0 M Exemption: 506(b) · Duration: One year or less · Commission: $4,335,553 · Revenue: Decline to Disclose
Aerpio Pharmaceuticals Inc 2017-03-30 41.8 M Exemption: 506(b) · Duration: One year or less · Commission: $4,229,507 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001422142] 10-K
[0001422142] 10-Q
[0001422142] 3
[0001422142] 4
[0001422142] 5
[0001422142] 8-K
[0001422142] D
[0001422142] SC 13D
[0001422142] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
OrbiMed Advisors LLC Whitehawk Therapeutics Inc [2025-05-15] 0.0
Suvretta Capital Management LLC AADI Bioscience Inc [2025-03-11] 0.0
ABG Management Ltd AADI Bioscience Inc [2025-03-10] 0.0
QVT Financial LP AADI Bioscience Inc [2025-02-14] 0.0
BML Investment Partners LP AADI Bioscience Inc [2025-01-30] 0.0
Point72 Asset Management LP AADI Bioscience Inc [2025-01-29] 0.0
BML Investment Partners LP AADI Bioscience Inc [2024-12-31] 0.0
EcoR1 Capital LLC AADI Bioscience Inc [2024-09-03] 7.5
BML Investment Partners LP AADI Bioscience Inc [2024-08-28] 4.8
Satter Muneer A AADI Bioscience Inc [2022-10-04] 5.3
Venrock Healthcare Capital Partners II LP AADI Bioscience Inc [2022-02-14] 7.3
Desai Neil AADI Bioscience Inc [2021-09-08] 12.4
Biotechnology Value Fund L P AADI Bioscience Inc [2021-09-07] 2.9
Acuta Capital Partners LLC AADI Bioscience Inc [2021-09-07] 7.2
Vivo Panda LLC AADI Bioscience Inc [2021-09-02] 2.8
RA Capital Management LP Aerpio Pharmaceuticals Inc [2021-08-23] 5.22
RA Capital Management LP Aerpio Pharmaceuticals Inc [2021-07-12] 3.3
Avoro Capital Advisors LLC Aerpio Pharmaceuticals Inc [2021-06-04] 0.5
Point72 Asset Management LP Aerpio Pharmaceuticals Inc [2021-05-26] 3.9
Vanguard Group Inc Aerpio Pharmaceuticals Inc [2021-02-10] 5.76
Ikarian Capital LLC Aerpio Pharmaceuticals Inc [2021-01-11] 1.0
BML Investment Partners LP Aerpio Pharmaceuticals Inc [2020-03-09] 5.3
Kearny Venture Partners LP Aerpio Pharmaceuticals Inc [2017-03-28] 5.8
OrbiMed Advisors LLC Aerpio Pharmaceuticals Inc [2017-03-27] 16.3
Satter Muneer A Aerpio Pharmaceuticals Inc [2017-03-27] 12.0
Novartis BioVentures Ltd Aerpio Pharmaceuticals Inc [2017-03-27] 21.5
Venture Investors Early Stage Fund IV LP Aerpio Pharmaceuticals Inc [2017-03-27] 5.8
Form 3/4/5 Filer 2011 - 2026
Castelein Caley
Zeta Acquisition Corp II
Desai Neil
Maroun Richard E
Zhao Baiteng
Hirmand Mohammad
Reeve Emma
Avoro Ventures LLC
Aghazadeh Behzad
Avoro Capital Advisors LLC
Giacobello Scott M
Dugan Margaret
Ball Bryan
Lennon David James
Dornan David
Dalal Anupam
Hehenberger Karin M
ITRI Lorettta M
Delaney Brendan
Thibault Lance E
Cohen Cheryl
Dugel Pravin
Prelack Steven
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Marek Regina
Peters Kevin G
Gardner Joseph H
Khuong Chau Quang
Satter Muneer A
Rogers Michael W
Hoffman Stephen J
Novartis AG
Novartis BioVentures Ltd
Pakola Steve
Desai Dhaval
Weiss Paul M
Murphy James B
Isaly Samuel D
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Giacobello Scott M
Common Stock
2026-03-02 Sell 2,594 $3.31 8,586
Lennon David James
Common Stock
2026-03-02 Sell 5,100 $3.31 16,881
Ball Bryan
Common Stock
2026-03-02 Sell 1,834 $3.31 6,071
Ball Bryan
Common Stock
2026-03-01 Option exercise 5,000
Giacobello Scott M
Restricted Stock Units · derivative
2026-03-01 Option exercise 6,750 $0.00
Ball Bryan
Restricted Stock Units · derivative
2026-03-01 Option exercise 5,000 $0.00
Lennon David James
Restricted Stock Units · derivative
2026-03-01 Option exercise 16,250 $0.00
Giacobello Scott M
Common Stock
2026-03-01 Option exercise 6,750
Lennon David James
Common Stock
2026-03-01 Option exercise 16,250
Dugan Margaret
Restricted Stock Units · derivative
2025-12-01 Grant 55,309 $0.00
Dugan Margaret
Stock option (right to buy) · derivative
2025-12-01 Grant 650,000 $0.00
Zhao Baiteng
Stock Option (right to buy) · derivative
2025-06-17 Grant 40,006 $0.00
Reeve Emma
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Desai Neil
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Hirmand Mohammad
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Maroun Richard E
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Castelein Caley
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Dalal Anupam
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Avoro Ventures LLC +2
Stock Option (right to buy) · derivative
2025-06-12 Grant 40,006 $0.00
Ball Bryan
Restricted Stock Units · derivative
2025-04-01 Grant 366,532 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 62 35,208,927
2025-12-31 48 32,977,502
2025-09-30 41 28,831,851
2025-06-30 40 29,433,079
2025-03-31 51 31,815,151
2024-12-31 54 14,983,187
2024-09-30 53 12,003,038
2024-06-30 66 11,483,327
2024-03-31 61 14,151,406
2023-12-31 66 13,314,097
2023-09-30 74 14,471,939
2023-06-30 68 14,071,864
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 24,363 24,363
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com